Labeling and artwork are vital components of the life sciences industry, as they ensure regulatory compliance and can be used in packaging, online, and in the supply chain. Failure to comply with Good Manufacturing Practice (GMP) requirements, which include proofreading and change control, can lead to errors in labeling content, resulting in significant fines and drug recalls. In this viewpoint, we examine the evolving labeling and artwork landscape for the biopharmaceutical and medical device industries, current market trends, and the provider landscape, along with possible synergies. Industry Life Sciences BPS Geography Global Contents In this report, we examine: The evolving labeling and artwork landscape for biopharma and medical devices industries Current market trends The provider landscape and possible synergies Membership (s) Life Sciences Business Process Sourcing and Vendor Management